Surgical technique may reduce positive margin rate in breast cancer patients with DCIS
(Wake Forest Baptist Medical Center) According to the American Cancer Society, a noninvasive breast cancer called ductal carcinoma in situ (DCIS) accounts for approximately one of every four new breast cancer cases in the United States. If left untreated, DCIS has the potential to evolve into invasive cancer, so many patients choose to have breast-conserving surgery or mastectomy after a diagnosis. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 5, 2021 Category: Cancer & Oncology Source Type: news

More accurate method to predict long term outcomes for pre-invasive breast cancer
(Queen Mary University of London) A study by Queen Mary University of London researchers, funded by Cancer Research UK, confirms the role of the oestrogen receptor biomarker in ductal carcinoma in situ and presents a new and more accurate method to predict long term outcomes for this pre-invasive stage of breast cancer. The study is published in Clinical Cancer Research. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 16, 2021 Category: International Medicine & Public Health Source Type: news

Moffitt researchers identify how cancer cells adapt to survive harsh tumor microenvironments
(H. Lee Moffitt Cancer Center& Research Institute) To better understand the conditions that select for the Warburg Effect and the mechanisms where cells can express this metabolic adaptation, Moffitt researchers subjected nonmalignant cells to the harsh tumor microenvironment that is present during early carcinogenesis, known as ductal carcinoma in situ. In a new research article published in the Proceedings of the National Academy of Sciences, the Moffitt team shows that these conditions select for cells to express a Warburg Effect. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 19, 2021 Category: Cancer & Oncology Source Type: news

Pembrolizumab not cost effective in BCG-unresponsive bladder carcinoma in situ
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - January 1, 2021 Category: Drugs & Pharmacology Source Type: news

Addition of Radiotherapy for DCIS Cuts Risk for Subsequent Cancer
FRIDAY, Oct. 16, 2020 -- For women with ductal carcinoma in situ (DCIS), the risk for developing subsequent ipsilateral in situ (iDCIS) and invasive breast cancer (iBC) is lower for those receiving breast-conserving surgery (BCS) and radiotherapy... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 16, 2020 Category: Pharmaceuticals Source Type: news

Radiation Plus Surgery May Be Best Against an Early Form of Breast Cancer
MONDAY, Oct. 5, 2020 -- Research following patients for nearly three decades finds that surgery plus radiation beats surgery alone for women with ductal carcinoma in situ (DCIS) -- a common, early form of breast cancer that can become invasive... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 5, 2020 Category: General Medicine Source Type: news

Ductal Carcinoma In Situ Tied to Threefold Higher Risk for Death
Risk for dying from breast cancer remains elevated 15 years after initial diagnosis (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 2, 2020 Category: Cancer & Oncology Tags: Family Medicine, Geriatrics, Gynecology, Internal Medicine, Oncology, Journal, Source Type: news

Ductal Carcinoma In Situ Tied to Threefold Higher Risk for Death
FRIDAY, Oct. 2, 2020 -- There is a threefold higher risk for dying of breast cancer after a diagnosis of ductal carcinoma in situ (DCIS), according to a study published online Sept. 16 in JAMA Network Open. Vasily Giannakeas, M.P.H., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 2, 2020 Category: Pharmaceuticals Source Type: news

Threefold Higher Risk for Breast Cancer Death With DCIS Threefold Higher Risk for Breast Cancer Death With DCIS
Compared to the general population, women with ductal carcinoma in situ (DCIS) were more than three times more likely to die from breast cancer; the risk was particularly high for Black women and young women.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 18, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Women with DCIS have 3x the risk of breast cancer death
A new study adds weight to the belief that ductal carcinoma in situ (DCIS)...Read more on AuntMinnie.comRelated Reading: Delayed breast cancer surgery not tied to worse outcomes Preop MRI finds 11% more cancer in women with DCIS Years later, DCIS tied to more imaging but not anxiety Black women still at higher risk of breast cancer death Does imaging modality influence DCIS recurrence? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 17, 2020 Category: Radiology Source Type: news

Surgical Delays Not Life-Threatening in Early Breast Cancer
WEDNESDAY, Aug. 12, 2020 -- Surgical delays do not seem to be life-threatening for women with ductal carcinoma in situ (DCIS) or with early-stage estrogen receptor-positive (ER+) breast cancer, according to a study published online Aug. 6 in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 12, 2020 Category: Pharmaceuticals Source Type: news

Carcinoma in Situ of the Bladder: Why Is It Underdetected? Carcinoma in Situ of the Bladder: Why Is It Underdetected?
The diagnosis of carcinoma in situ of the bladder remains challenging. Could certain new diagnostic techniques improve the detection rate?Current Opinion in Urology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 18, 2020 Category: Consumer Health News Tags: Urology Journal Article Source Type: news

Increased Risk for Invasive Breast Cancer After DCIS Increased Risk for Invasive Breast Cancer After DCIS
A new analysis shows that any diagnosis of ductal carcinoma in situ is associated with a long-term risk of invasive breast cancer and that treatment lowers this risk.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - June 4, 2020 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Very Early-Stage Breast Cancer Ups Long-Term Odds for Invasive Tumors: Study
FRIDAY, May 29, 2020 -- Women with cancerous cells in their milk ducts -- also known as DCIS -- are at a high risk for developing fatal breast cancer, British researchers report. DCIS is short for ductal carcinoma in situ, an early form of breast... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 29, 2020 Category: General Medicine Source Type: news

Trastuzumab achieves slight reduction in recurrence for women with HER2-positive DCIS
(NRG Oncology) The addition of the monoclonal antibody therapy Trastuzumab to radiotherapy did not reach the protocol objective of a 36% reduction in the ipsilateral breast tumor recurrence rate for women with HER2-positive ductal carcinoma in situ (DCIS) on the NRG Oncology clinical trial NSABP B-43. The trial did find a statistically non-significant, modest (19%) reduction in the rate of recurrence among women that received trastuzumab, but this difference was not statistically significant. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 29, 2020 Category: Cancer & Oncology Source Type: news